admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment...

New Psychedelic Entactogens: Designer Drugs Produce Designer Effects

PT354 – Laura Guzmán-Dávalos – Psilocybe, Microdosing, and Multigenerational Mycology

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences

Algernon Pharmaceuticals Secures Lead Sponsorship of 2022 Wonderland Psychedelic Conference in...

Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health...

MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in...

Small Pharma to Participate in Upcoming September Investor Conferences

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of...

1...121122123...218 Page 122 of 218

EDITOR PICKS

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin